CN Patent

CN116726145A — 一种稳定的酯肽类药物组合物

Assigned to Hainan Poly Pharm Co ltd · Expires 2023-09-12 · 3y expired

What this patent protects

本发明属于医疗领域，具体涉及一种稳定的酯肽类药物组合物。所述酯肽类药物组合物，包括酯肽类药物和锌源。所述组合物用于预防、治疗敏感菌株的感染，采用锌离子(Zn)作为稳定剂，可以降低酯肽类药物在水溶液中的降解速率，同时组合物在2‑8℃的稳定性至少在6个月以上。

USPTO Abstract

本发明属于医疗领域，具体涉及一种稳定的酯肽类药物组合物。所述酯肽类药物组合物，包括酯肽类药物和锌源。所述组合物用于预防、治疗敏感菌株的感染，采用锌离子(Zn)作为稳定剂，可以降低酯肽类药物在水溶液中的降解速率，同时组合物在2‑8℃的稳定性至少在6个月以上。

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN116726145A
Jurisdiction: CN
Classification: —
Expires: 2023-09-12
Drug substance claim: No
Drug product claim: No
Assignee: Hainan Poly Pharm Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.